A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2011
10/27/2011	US20110262520 Layered drug delivery device
10/27/2011	US20110262519 Method of improving lens rotation
10/27/2011	US20110262518 Treatment for cardiac injuries created by myocardial infarction
10/27/2011	US20110262517 Chirally pure isomers of itraconazole and inhibitors of lanosterol 14a-demethylase for use as angiogenesis inhibitors
10/27/2011	US20110262516 Autologous cells on a support matrix for tissue repair
10/27/2011	US20110262506 Topical compositions containing coated active agents
10/27/2011	US20110262503 Flowable Wound Matrix and its Preparation and Use
10/27/2011	US20110262502 Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
10/27/2011	US20110262500 Conjugates comprising nanoparticles coated with platinum containing compounds
10/27/2011	US20110262499 Topical herbal formulation for treatment of acne and skin disorders
10/27/2011	US20110262498 Biologic Scaffold for Prevention of Pulmonary Fibrosis
10/27/2011	US20110262497 Novel ezetimibe formulations
10/27/2011	US20110262496 Therapeutic formulation for reduced drug side effects
10/27/2011	US20110262495 Pharmaceutical emulsion compositions comprising progestogen
10/27/2011	US20110262494 Low-oil pharmaceutical emulsion compositions comprising progestogen
10/27/2011	US20110262493 Multi-layered hydrogel constructs and associated methods
10/27/2011	US20110262492 Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors
10/27/2011	US20110262491 Emulsions and methods of making nanocarriers
10/27/2011	US20110262490 Polymer-agent conjugates, particles, compositions, and related methods of use
10/27/2011	US20110262489 Hyaluronic acid cryogel - compositions, uses, processes for manufacturing
10/27/2011	US20110262488 Novel HIV-1 Envelope Glycoprotein
10/27/2011	US20110262486 Bone implant and manufacturing method thereof
10/27/2011	US20110262369 Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug
10/27/2011	US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use
10/27/2011	US20110262357 Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy
10/27/2011	US20110262356 Active Particles for Bio-Analytical Applications and Methods for Preparation Thereof
10/27/2011	US20110262347 Methods and compositions for enhanced delivery of compounds
10/27/2011	DE102007056462B4 Einwegampulle für eine Vorrichtung zur Erzeugung von Aerosolen Disposable vial for a device for the generation of aerosols
10/27/2011	CA2807374A1 Aliskiren in form of a solid dispersion
10/27/2011	CA2800260A1 Compositions and method for the treatment of multiple myeloma
10/27/2011	CA2797098A1 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof
10/27/2011	CA2796978A1 A process for particle processing of active pharmaceutical ingredients
10/27/2011	CA2796725A1 Uses of natriuretic peptide constructs
10/27/2011	CA2796494A1 Pharmaceutical composition
10/27/2011	CA2795521A1 A solid pharmaceutical composition for neutralizing stomach acid
10/27/2011	CA2794439A1 Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment
10/27/2011	CA2727957A1 Pharmaceutical composition comprising levamlodipine and indapamide
10/26/2011	EP2380973A1 Drug made from stem cells with reprogrammed cell signaling, method for producing said preparation and the use thereof
10/26/2011	EP2380658A2 Easier vesicle preparations using alkyl poly-pentosides and use of said preparations
10/26/2011	EP2380657A1 Ceramide dispersion, and process for producing same
10/26/2011	EP2380582A1 Low-concentration nutritional composition
10/26/2011	EP2380579A1 Beneficial effects of increasing local blood flow
10/26/2011	EP2380563A1 A enteric formulation of duloxetine and its core and prepration method
10/26/2011	EP2380562A1 A controlled-released osmotic pump tablet with lubricating layer and the preparation thereof
10/26/2011	EP2380561A1 Extended release formulation comprising indapamide
10/26/2011	EP2380560A1 Matrix tablets containing pramipexol
10/26/2011	EP2380559A1 Liposome preparation method
10/26/2011	EP2380558A1 Arranging interaction and back pressure chambers for microfluidization
10/26/2011	EP2380539A1 Pressure-sensitive adhesive tape package
10/26/2011	EP2379112A2 Gel adapted for transmitting ultrasound waves, method for making said gel, and bag containing same
10/26/2011	EP2379111A1 Narcotic drug formulations with decreased abuse potential
10/26/2011	EP2379100A1 Method for treating hyperglycemia with glp-1
10/26/2011	EP2379079A1 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
10/26/2011	EP2379078A2 Topical formulations of flap inhibitors for administration to an eye
10/26/2011	EP2379077A2 Pharmaceutical composition
10/26/2011	EP2379065A2 Capecitabine rapidly disintegrating tablets
10/26/2011	EP2379064A2 Long circulating nanoparticles for sustained release of therapeutic agents
10/26/2011	EP2379063A1 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
10/26/2011	EP2379062A1 Pharmaceutical composition comprising one or more fumaric acid esters
10/26/2011	EP2379061A2 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
10/26/2011	EP2379060A2 Extended-release pharmaceutical formulations
10/26/2011	EP2379059A1 Controlled releasing composition
10/26/2011	EP2379058A1 Retigabine tablets, preferably having modified release
10/26/2011	EP2379057A1 Phenylephrine formulations with improved stability
10/26/2011	EP2379056A2 Solid pharmaceutical composition comprising at least one stabilizing agent
10/26/2011	EP2379055A1 Method of making sustained release microparticles
10/26/2011	EP2379054A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
10/26/2011	EP2379053A1 Prophylactic/therapeutic agent for cancer
10/26/2011	EP2379044A1 Method to authenticate genuine tablets manufactured by compressing powder
10/26/2011	EP2378883A2 Zaleplon gastroretentive drug delivery system
10/26/2011	EP2378876A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
10/26/2011	EP2378873A1 Method of treating neuropathic pain
10/26/2011	EP2378872A1 Acne vulgaris treatment regimen
10/26/2011	EP2180027B1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel
10/26/2011	EP2142169B1 Aqueous pharmaceutical preparation
10/26/2011	EP2136788B1 Cancer cell targeting using nanoparticles
10/26/2011	EP2079446B1 Paliperidone sustained release formulation
10/26/2011	EP2010152B1 Magnetic nanoparticles compositions and uses thereof
10/26/2011	EP1951267B1 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same
10/26/2011	EP1684719B1 Alpha 1-antitrypsin compositions and treatment methods using such compositions
10/26/2011	EP1602360B1 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof
10/26/2011	EP1587477B1 Odorless formulation for treating mucosal discontinuities
10/26/2011	EP1429729B1 Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin
10/26/2011	CN202015357U Thin cataplasm
10/26/2011	CN202015356U Combined capsule
10/26/2011	CN1939449B Infantile heat-clearing and antitussive dispersing tablets
10/26/2011	CN1931276B Headache treating Chinese medicine composition and its prepn process
10/26/2011	CN1901922B Compositions and uses thereof
10/26/2011	CN1868503B Preparation method of extractive of Herba Rabdosiae diterpene
10/26/2011	CN1867323B Low-dose tablets having a network of polymers
10/26/2011	CN1823961B Compound Chinese medicine for treating cough and panting, acute bronchitis caused by common cold and its preparation method
10/26/2011	CN1813937B Compound formulation for treating hyperlipidemia and its preparing method
10/26/2011	CN1813895B Chinese medicine formulation of lunar caustic for activating blood flow and removing blood stasis, and stopping pain, and its preparing method
10/26/2011	CN1762967B Enoxolone derivative, preparation method and uses
10/26/2011	CN1662243B Pharmaceutical composition
10/26/2011	CN102227442A Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/26/2011	CN102227216A Pharmaceutical dosage form comprising nifedipine or nisoldipine and angiotensin-ii antagonist and/or diuretic
10/26/2011	CN102227215A Surface active proteins as excipients in solid pharmaceutical formulations
10/26/2011	CN102227214A Compositions with reduced dimer formation
10/26/2011	CN102227213A Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides

1 ... 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 ... 2991